The inflence of LPS on the thyroid gland leads to more intensive synthesis and release of thyroglobulin into the follicle lumen and inhibition of its resorption and proteolysis, which reduces the production of thyroxine. Treatment with thyroid-stimulating hormone normalizing the secretory processes in the follicular thyrocytes is a pathogenetically justifi ed method for correction of non-thyroidal illness syndrome in acute endotoxicosis.
Similar content being viewed by others
References
J. P. Nicola, M. L. Velez, A. M. Lucero, et al., Endocrinology, 150, No. 1, 500-508 (2009).
G. Van den Berghe, F. de Zegher, and R. Bouillon, J. Clin. Endocrinol. Metab., 83, No. 6, 1827-1834 (1998).
M. L. Velez, E. Constamagna, E. T. Kimura, et al., Endocrinology, 147, No. 7, 3260-3275 (2006).
M. Warner and G. Beckett, J. Endocrinology, 205, No. 1, 1-13 (2010).
J. Yu and R. J. Koenig, Endocrinology, 147, No. 7, 3580-3585 (2006).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 152, No. 8, pp. 215-219, August, 2011
Rights and permissions
About this article
Cite this article
Yaglova, N.V. Disorders in the Secretory Cycle of Follicular Thyrocytes and Their Correction with Thyrotropic Hormone in Experimental Non-Thyroidal Illness Syndrome. Bull Exp Biol Med 152, 253–257 (2011). https://doi.org/10.1007/s10517-011-1501-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-011-1501-y